RE:Interesting committee they've formed Interesting group indeed but we should not expect those Committee members to spend much time on this ...They will review the data submitted by THTX and come up with opinions/ recommendations as to the path forward .... Hard to imagine that they can provide anything other than : try this try that have you thought about this and about that
It would be a lot more productive if there were a lot of data from which they could draw conclusions
Trials serve one purpose .... to prove or disprove
I am of the opinion that the job ahead is humongous and for the sake of patients I hope that they can find a glimmer of hope sufficient to get a phama interested ..... That is the best we can hope for
Wino115 wrote: Very interesting group put together for this stage.
- The Yale doctor is the one who trialed docetaxal through all three phases for prostate cancer. So a specialist in what taxols can do. Hopefully he can also tap into that Yale PDC connection. So he might be the chemo bomb expert.
- The Texas doctor (who's Canadian actually) specializes almost exclusively in doing Phase 1 trials for oncology. He also started a cancer genome project, so I assume he might be the expert around the target and sort1, maybe toxicity and safety issues to. Also perhaps dosing logic.
- The Tennesee doctor seems to be a leader in gynecological and overall research, she seems to be a leader in the conferences and has a lot of social media followers. Seems sort of an all around type.
We know the lead investigator is the MD Anderson women along with those other 3-4 clinics and then Rothemberg sheparded 3-4 oncology drugs for Pfizer.
Seems like they have the key bases covered.